Gefitinib for advanced non-small cell lung cancer: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Gefitinib for Advanced Non-small Cell Lung Cancer: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436068/all/Modifications_of_the_Epley__canalith_repositioning__manoeuvre_for_posterior_canal_benign_paroxysmal_positional_vertigo__BPPV__New. Accessed 28 March 2024.
Gefitinib for advanced non-small cell lung cancer: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436068/all/Modifications_of_the_Epley__canalith_repositioning__manoeuvre_for_posterior_canal_benign_paroxysmal_positional_vertigo__BPPV__New. Accessed March 28, 2024.
Gefitinib for advanced non-small cell lung cancer: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/436068/all/Modifications_of_the_Epley__canalith_repositioning__manoeuvre_for_posterior_canal_benign_paroxysmal_positional_vertigo__BPPV__New
Gefitinib for Advanced Non-small Cell Lung Cancer: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2024 March 28]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436068/all/Modifications_of_the_Epley__canalith_repositioning__manoeuvre_for_posterior_canal_benign_paroxysmal_positional_vertigo__BPPV__New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Gefitinib for advanced non-small cell lung cancer: Cochrane systematic review
ID - 436068
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436068/all/Modifications_of_the_Epley__canalith_repositioning__manoeuvre_for_posterior_canal_benign_paroxysmal_positional_vertigo__BPPV__New
DB - Evidence Central
DP - Unbound Medicine
ER -